Amgen Inc.
KRAS G12C inhibitors and methods of using the same

Abstract:

Provided herein are methods of treating cancer with KRAS G12C inhibitors of Formula I and compositions of the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers. ##STR00001##